Time Course Global Gene Expression Analysis of an in Vivo Candida biofilm

Journal of Infectious Diseases

Volumn 200, Issue 2, 2009, Pages 307-313

  Nett, Jeniel E ^a   Lepak, Alexander J ^a   Marchillo, Karen ^a   Andes, David R ^a,b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b 600 Hiahland Ave ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLUCAN; ERGOSTEROL; MESSENGER RNA;

AMINO ACID METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOFILM; CANDIDA; CANDIDA ALBICANS; CANDIDIASIS; CARBOHYDRATE METABOLISM; CARBOHYDRATE SYNTHESIS; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CONTROLLED STUDY; ENERGY METABOLISM; GENE EXPRESSION; GENETIC ASSOCIATION; HOST PATHOGEN INTERACTION; IN VIVO STUDY; MICROARRAY ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN MODIFICATION; PROTEIN SYNTHESIS; RAT; STEROL SYNTHESIS;

ANIMALS; BIOFILMS; CANDIDA ALBICANS; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; DISEASE MODELS, ANIMAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, FUNGAL; RATS; RNA, FUNGAL; RNA, MESSENGER;

EID: 67650665320     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/599838     Document Type: Article

References (50)

1. Kojic EM, Darouiche RO. Candida infections of medical devices. Clin Microbiol Rev 2004; 17:255-67.
2. Douglas LJ. Candida biofilms and their role in infection. Trends Microbiol 2003;11:30-6.
3. Baillie GS, Douglas LJ. Matrix polymers of Candida biofilms and their possible role in biofilm resistance to antifungal agents. J Antimicrob Chemother 2000; 46:397-403.
4. Mukherjee PK, Chandra J, Kuhn DM, Ghannoum MA. Mechanism of fluconazole resistance in Candida albicans biofilms: phase-specific role of efflux pumps and membrane sterols. Infect Immun 2003; 71: 4333-40.
5. Ramage G, Bachmann S, Patterson TF, Wickes BL, Lopez-Ribot JL. Investigation of multidrug efflux pumps in relation to fluconazole resistance in Candida albicans biofilms. J Antimicrob Chemother 2002; 49:973-80.
6. Chandra J, Kuhn DM, Mukherjee PK, Hoyer LL, McCormick T, Ghannoum MA. Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J Bacteriol 2001; 183: 5385-94.
7. Garcia-Sanchez S, Aubert S, Iraqui I, Janbon G, Ghigo JM, d'Enfert C. Candida albicans biofilms: a developmental state associated with specific and stable gene expression patterns. Eukaryot Cell 2004; 3: 536-45.
8. Esteban PF, Rios I, Garcia R, et al. Characterization of the CaENG1 gene encoding an endo-1,3-beta-glucanase involved in cell separation in Candida albicans. Curr Microbiol 2005;51:385-92.
9. Cao YY, Cao YB, Xu Z, et al. cDNA microarray analysis of differential gene expression in Candida albicans biofilm exposed to farnesol. Antimicrob Agents Chemother 2005; 49:584-9.
10. Nett J, Andes D. Candida albicans biofilm development, modeling a host-pathogen interaction. Curr Opin Microbiol 2006; 9:340-5.
11. Andes D, Nett J, Oschel P, Albrecht R, Marchillo K, Pitula A. Development and characterization of an in vivo central venous catheter Candida albicans biofilm model. Infect Immun 2004;72:6023-31.
12. Andes D, Lepak A, Pitula A, Marchillo K, Clark J. A simple approach for estimating gene expression in Candida albicans directly from a systemic infection site. J Infect Dis 2005; 192:893-900.
13. Nett J, Lincoln L, Marchillo K, Andes D. β-1,3 glucan as a test for central venous catheter biofilm infection. J Infect Dis 2007; 195: 1705-12.
14. Nett J, Lincoln L, Marchillo K, et al. Putative role of beta-1,3 glucans in Candida albicans biofilm resistance. Antimicrob Agents Chemother 2007; 51:510-20.
15. Lepak A, Nett J, Lincoln L, Marchillo K, Andes D. Time course of microbiologic outcome and gene expression in Candida albicans during and following in vitro and in vivo exposure to fluconazole. Antimicrob Agents Chemother 2006;50:1311-9.
16. Nobile CJ, Solis N, Myers CL, et al. Candida albicans transcription factor Rim101 mediates pathogenic interactions through cell wall functions. Cell Microbiol 2008; 10:2180-96.
17. -△△CT method. Methods 2001;25:402-8.
18. Donlan RM. Biofilm formation: a clinically relevant microbiological process. Clin Infect Dis 2001;33:1387-92.
19. Mukherjee PK, Mohamed S, Chandra J, et al. Alcohol dehydrogenase restricts the ability of the pathogen Candida albicans to form a biofilm on catheter surfaces through an ethanol-based mechanism. Infect Immun 2006;74:3804-16.
20. Nobile CJ, Nett JE, Andes DR, Mitchell AP. Function of Candida albicans adhesin Hwp1 in biofilm formation. Eukaryot Cell 2006;5: 1604-10.
21. Nobile CJ, Andes DR, Nett JE, et al. Critical role of Bcr1-dependent adhesins in C. albicans biofilm formation in vitro and in vivo. PLoS Pathog 2006; 2:e63.
22. Zhao X, Oh SH, Yeater KM, Hoyer LL. Analysis of the Candida albicans Als2p and Als4p adhesins suggests the potential for compensatory function within the Als family. Microbiology 2005; 151:1619-30.
23. Khot PD, Suci PA, Miller RL, Nelson RD, Tyler BJ. A small subpopulation of blastospores in Candida albicans biofilms exhibit resistance to amphotericin B associated with differential regulation of ergosterol and beta-l,6-glucan pathway genes. Antimicrob Agents Chemother 2006;50:3708- 16.
24. Fradin C, Kretschmar M, Nichterlein T, Gaillardin C, d'Enfert C, Hube B. Stage-specific gene expression of Candida albicans in human blood. Mol Microbiol 2003;47:1523-43.
25. Lorenz MC, Fink GR. The glyoxylate cycle is required for fungal virulence. Nature 2001;412:83-6.
26. Kumamoto CA, Vinces MD. Alternative Candida albicans lifestyles: growth on surfaces. Annu Rev Microbiol 2005;59:113-33.
27. Hawser SP, Douglas LJ. Biofilm formation by Candida species on the surface of catheter materials in vitro. Infect Immun 1994;62:915-21.
28. Richard ML, Nobile CJ, Bruno VM, Mitchell AP. Candida albicans biofilm-defective mutants. Eukaryot Cell 2005;4:1493-502.
29. Nobile CJ, Schneider HA, Nett JE, et al. Complementary adhesin function in C. albicans biofilm formation. Curr Biol 2008; 18:1017-24.
30. Murillo LA, Newport G, Lan CY, Habelitz S, Dungan J, Agabian NM. Genome-wide transcription profiling of the early phase of biofilm formation by Candida albicans. Eukaryot Cell 2005; 4:1562-73.
31. Regenberg B, Holmberg S, Olsen LD, Kielland-Brandt MC. Dip5p mediates high-affinity and high-capacity transport of L-glutamate and L-aspartate in Saccharomyces cerevisiae. Curr Genet 1998;33:171-7.
32. Regenberg B, During-Olsen L, Kielland-Brandt MC, Holmberg S. Substrate specificity and gene expression of the amino-acid permeases in Saccharomyces cerevisiae. Curr Genet 1999;36:317-28.
33. Hawser SP, Baillie GS, Douglas LJ. Production of extracellular matrix by Candida albicans biofilms. J Med Microbiol 1998;47:253-6.
34. Ramage G, VandeWalle K, Lopez-Ribot JL, Wickes BL. The filamentation pathway controlled by the Efgl regulator protein is required for normal biofilm formation and development in Candida albicans. FEMS Microbiol Lett 2002;214:95-100.
35. Schweizer A, Rupp S, Taylor BN, Rollinghoff M, Schroppel K. The TEA/ATTS transcription factor CaTec1p regulates hyphal development and virulence in Candida albicans. Mol Microbiol 2000; 38:435-45.
36. Braun BR, Johnson AD. Control of filament formation in Candida albicans by the transcriptional repressor TUP1. Science 1997;277: 105-9.
37. Hornby JM, Jensen EC, Lisec AD, et al. Quorum sensing in the dimorphic fungus Candida albicans is mediated by famesol. Appl Environ Microbiol 2001;67:2982-92.
38. Oh KB, Miyazawa H, Naito T, Matsuoka H. Purification and characterization of an autoregulatory substance capable of regulating the morphological transition inCandida albicans. Proc Natl Acad Sci U S A 2001;98:4664-8.
39. Ramage G, Saville SP, Wickes BL, Lopez-Ribot JL. Inhibition of Candida albicans biofilm formation by farnesol, a quorum-sensing molecule. Appl Environ Microbiol 2002; 68:5459-63.
40. Chen H, Fujita M, Feng Q, Clardy J, Fink GR. Tyrosol is a quorumsensing molecule in Candida albicans. Proc Natl Acad Sci U S A 2004; 101:5048-52.
41. Kruppa M, Krom BP, Chauhan N, Bambach AV, Cihlar RL, Calderone RA. The two-component signal transduction protein Chk1p regulates quorum sensing in Candida albicans. Eukaryot Cell 2004;3:1062-5.
42. Barker KS, Crisp S, Wiederhold N, et al. Genome-wide expression profiling reveals genes associated with amphotericin B and fluconazole resistance in experimentally induced antifungal resistant isolates of Candida albicans. J Antimicrob Chemother 2004;54:376-85.
43. Sarthy AV, McGonigal T, Coen M, Frost DJ, Meulbroek JA, Goldman RC. Phenotype in Candida albicans of a disruption of the BGL2 gene encoding a 1,3-beta-glucosyltransferase. Microbiology 1997; 143: 367-76.
44. Mio T, Adachi-Shimizu M, Tachibana Y, et al. Cloning of the Candida albicans homolog of Saccharomyces cerevisiae GSC1/FKS1 and its involvement in beta-l,3-glucan synthesis. J Bacteriol 1997; 179:4096-105.
45. Nett J, Lincoln L, Marchillo K, et al. Putative role of beta-1,3 glucans in Candida albicans biofilm resistance. Antimicrob Agents Chemother 2007;51:510-520.
46. Ramage G, Saville SP, Thomas DP, Lopez-Ribot JL. Candida biofilms: an update. Eukaryot Cell 2005; 4:633-8.
47. Kuhn DM, Ghannoum MA. Candida biofilms: antifungal resistance and emerging therapeutic options. Curr Opin Investig Drugs 2004;5: 186-97.
48. Mateus C, Crow SA Jr, Ahearn DG. Adherence of Candida albicans to silicone induces immediate enhanced tolerance to fluconazole. Antimicrob Agents Chemother 2004; 48:3358-66.
49. Saidane S, Weber S, De Deken X, St-Germain G, Raymond M. PDR 16-mediated azole resistance in Candida albicans. Mol Microbiol 2006; 60:1546-62.
50. Kumamoto CA. A contact-activated kinase signals Candida albicans invasive growth and biofilm development. Proc Natl Acad Sci U S A 2005; 102:5576-81.